Un-Audited Financial Results for the quarter ended 31.12.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Hari Chemicals Export Ltd reported its Q3 FY26 results (quarter ended Dec 31, 2025) along with nine-month figures. Revenue from operations for the quarter stood at Rs 4,448.54 lakhs vs Rs 3,901.62 lakhs in Q3 FY25, a growth of about 14%. For the nine months ended Dec 2025, revenue jumped to Rs 14,328.04 lakhs from Rs 10,616.97 lakhs in the same period last year, a robust growth of roughly 35%. The company posted a net profit for the quarter and remains profitable on a 9-month basis. The auditor, Kailash Chand Jain & Co., issued a clean (unqualified) limited review report on both standalone and consolidated results, with no qualifications, emphasis of matter, or audit concerns flagged. The company also confirmed that 6,05,494 equity shares were allotted on Dec 4, 2025 upon conversion of an equal number of zero-coupon CCDs, and there is no deviation in the use of the Rs 14.74 crore raised through preferential issues/allotments.
Strong 9-month revenue growth (~35% YoY) and a clean audit review are positives for the stock. However, the recent conversion of CCDs into equity shares means some dilution for existing shareholders, which investors should factor in. Overall, the results signal healthy business momentum for small investors to track.